Also see: Cisco, CVS: Analysts' New Ratings
Editor's Note: Green and red arrows refer to intraday stock price movement.
NEW YORK ( TheStreet) -- STOCK COMMENTS / EPS CHANGES
Accretive Health (AH) numbers lowered at Goldman. Shares of AH now seen reaching $26. Estimates also cut, as the company is seeing higher operating costs. Neutral rating.Brady (BRC - Get Report) estimates, target raised at Keybanc. Shares of BRC now seen reaching $44, according to Keybanc. Estimates also increased, as the company is leveraged to positive macro trends. Buy rating. Bristow (BRS - Get Report) estimates, target raised at Goldman. Shares of BRS now seen reaching $57. Estimates also increased, as the company is seeing higher sales. Neutral rating. Cisco Systems (CSCO - Get Report) estimates upped at Goldman through 2012. Company is boosting margins through cost cuts. Neutral rating and $21 price target. Costco (COST - Get Report) estimates, target boosted at Jefferies. Shares of COST now seen reaching $93, according to Jefferies. Estimates also upped, as the company is seeing higher sales and buying back stock. Buy rating. Covidien (COV) target raised at Morgan Stanley. Shares of COV now seen reaching $63, according to Morgan Stanley. Emerging market growth is accelerating and the company is returning capital to investors. Overweight rating. Computer Sciences (CSC) numbers cut at Goldman. CSC estimates were reduced through 2013, Goldman Sachs said. Lower expected organic growth will likely weigh on margins. Neutral rating and new $43 price target. Dollar Tree (DLTR) numbers upped at Jefferies. DLTR estimates were boosted through 2012, Jefferies said. Company could see more traffic, as consumers trade down because of rising gas prices. Buy rating and new $69 price target. DirecTV (DTV) target increased at Morgan Stanley. DTV target was raised to $57, Morgan Stanley said. Company is seeing better growth in Latin America. Overweight rating. JC Penney (JCP) numbers boosted at BMO. Shares of JCP now seen reaching $35, according to BMO Capital. Estimates also upped, as the company could buy back even more shares. Market Perform rating. Macy's (M - Get Report) price target boosted at Citi. M price target increased to $44 from $32. Strong 1Q11, momentum should carry to 2Q11, Citigroup said. Maintain Buy rating.